These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 6796317)

  • 41. Amyloid fibril protein AA in Papua New Guinean amyloidosis.
    Anders RF; Price MA; Wilkey IS; Husby G; Takitaki F; Natvig JB; McAdam KP
    Clin Exp Immunol; 1976 Apr; 24(1):49-53. PubMed ID: 820500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Partial characterization of amyloid proteins in inherited amyloidosis with lattice corneal dystrophy and in secondary amyloidosis.
    Meretoja J; Hollmén T; Meretoja T; Penttinen R
    Med Biol; 1978 Feb; 56(1):17-22. PubMed ID: 305513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roles of immunoglobulins in amyloidogenesis in cutaneous nodular amyloidosis.
    Ito K; Hashimoto K; Kambe N; Van S
    J Invest Dermatol; 1987 Oct; 89(4):415-8. PubMed ID: 3117902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Subcutaneous nodular amyloidosis: a case report and review of the literature.
    Nguyen TU; Oghalai JS; McGregor DK; Janssen NM; Huston DP
    Hum Pathol; 2001 Mar; 32(3):346-8. PubMed ID: 11274647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Binding of nascent collagen by amyloidogenic light chains and amyloid fibrillogenesis in monolayers of human fibrocytes.
    Harris DL; King E; Ramsland PA; Edmundson AB
    J Mol Recognit; 2000; 13(4):198-212. PubMed ID: 10931557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nodular localized cutaneous amyloidosis: detection of monoclonality of infiltrating plasma cells by polymerase chain reaction.
    Hagari Y; Mihara M; Hagari S
    Br J Dermatol; 1996 Oct; 135(4):630-3. PubMed ID: 8915162
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda) in two horses.
    Linke RP; Trautwein G
    Blut; 1989 Mar; 58(3):129-32. PubMed ID: 2495038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and antigenic behaviour of kappa I-immunoglobulin light-chain amyloid proteins.
    Westermark P; Sletten K; Natvig JB
    Acta Pathol Microbiol Scand C; 1981 Jun; 89(3):199-203. PubMed ID: 6171994
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pathogenesis, diagnosis and treatment of systemic amyloidosis.
    Pepys MB
    Philos Trans R Soc Lond B Biol Sci; 2001 Feb; 356(1406):203-10; discussion 210-1. PubMed ID: 11260801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lambda light chain deposition disease presenting as an amyloid-like arthropathy.
    Rivest C; Turgeon PP; Senécal JL
    J Rheumatol; 1993 May; 20(5):880-4. PubMed ID: 8336318
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Residual structures in the acid-unfolded states of Vlambda6 proteins affect amyloid fibrillation.
    Mishima T; Ohkuri T; Monji A; Kanemaru T; Abe Y; Ueda T
    J Mol Biol; 2009 Oct; 392(4):1033-43. PubMed ID: 19647748
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.
    Cohen D; Pras M; Franklin EC; Frangione B
    Am J Med; 1983 Mar; 74(3):513-8. PubMed ID: 6402931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary localized cutaneous amyloidosis--lichen amyloidosus. A case report.
    Gałazka K; Bogdaszewska-Czabanowska J; Setkowicz M; Stachura J
    Pol J Pathol; 1999; 50(2):119-22. PubMed ID: 10481537
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibril protein fragmentation pattern in systemic AL-amyloidosis.
    Enqvist S; Sletten K; Westermark P
    J Pathol; 2009 Dec; 219(4):473-80. PubMed ID: 19771564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advanced glycation end product-modified beta2-microglobulin is a component of amyloid fibrils of primary localized cutaneous nodular amyloidosis.
    Fujimoto N; Yajima M; Ohnishi Y; Tajima S; Ishibashi A; Hata Y; Enomoto U; Konohana I; Wachi H; Seyama Y
    J Invest Dermatol; 2002 Mar; 118(3):479-84. PubMed ID: 11874487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Idiopathic AL-kiv amyloidosis presenting as giant hepatomegaly.
    Pras M; Frangione B; Franklin EC; Gafni J
    Isr J Med Sci; 1982 Aug; 18(8):866-9. PubMed ID: 7118533
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biochemical characterisation of amyloid by endomyocardial biopsy.
    Benson MD; Breall J; Cummings OW; Liepnieks JJ
    Amyloid; 2009 Mar; 16(1):9-14. PubMed ID: 19291509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lambda III subgroup immunoglobulin light chains are precursor proteins of nodular pulmonary amyloidosis.
    Miura K; Shirasawa H
    Am J Clin Pathol; 1993 Nov; 100(5):561-6. PubMed ID: 8249896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.